Discounted Cash Flow

Insmed Inc.

INSM · Based on 10 years of SEC filings

DCF estimate unavailable — No positive free cash flow in recent history — company has not generated positive FCF

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income
Dividends

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

Free cash flow growth
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI)
10-year: — 5-year: — 3-year: —
Net income growth
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations)
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2016 $0 $-176.3m $-150.9m $-2.85
2017 $0 $-192.6m (-9.3%) $-162.6m (-7.8%) $-2.89 (-1.4%)
2018 $9.8m $-324.3m (-68.3%) $-271.1m (-66.7%) -3297.2% $-4.22 (-46.0%)
2019 $136.5m (1287.6%) $-254.3m (21.6%) $-292.9m (-8.1%) -186.4% (94.3%) $-3.01 (28.7%)
2020 $164.4m (20.5%) $-294.1m (-15.6%) $-225.6m (23.0%) -178.9% (4.0%) $-3.01 (0.0%)
2021 $188.5m (14.6%) $-434.7m (-47.8%) $-370.6m (-64.3%) -230.6% (-28.9%) $-3.88 (-28.9%)
2022 $245.4m (30.2%) $-481.5m (-10.8%) $-410.3m (-10.7%) -196.3% (14.9%) $-3.91 (-0.8%)
2023 $305.2m (24.4%) $-749.6m (-55.7%) $-549.5m (-33.9%) -245.6% (-25.1%) $-5.34 (-36.6%)
2024 $363.7m (19.2%) $-913.8m (-21.9%) $-705.8m (-28.4%) -251.2% (-2.3%) $-5.57 (-4.3%)
2025 $606.4m (66.7%) $-1.3b (-39.7%) $-967.6m (-37.1%) -210.5% (16.2%) $-6.42 (-15.3%)

Base FCF: (latest fiscal year)

Discount rate: %

Terminal growth:

Projection period: years

Alt A decline yrs:

Alt B total yrs:

Values abbreviated: b = billions, m = millions, k = thousands.

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF:

Terminal FCF:

Terminal value:

PV of terminal value:

Enterprise value (DCF):

DCF price per share:

Current price:

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) 10 + TV
Alt A (Gradual Decline)
Alt B (30yr Hard Stop) N/A

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model

No positive free cash flow in recent history — company has not generated positive FCF

Once the company meets all DCF eligibility criteria (sufficient history, profitability, growth trends), an estimate will become available automatically. No action is needed.